Literature DB >> 18926399

Late outcomes of pediatric heart transplantation are independent of pre-transplant diagnosis and prior cardiac surgical intervention.

Beatrice Dionigi1, Anees J Razzouk, Nahidh W Hasaniya, Richard E Chinnock, Leonard L Bailey.   

Abstract

BACKGROUND: An increasing number of children are being referred for cardiac transplantation after (1) failing conventional corrective or palliative surgical reconstruction, (2) after stabilization with mechanical circulatory support devices, and (3) when primary graft failure or advanced cardiac allograft vasculopathy are established.
METHODS: The records of 417 infants and children (age range, 0-18 years) who underwent cardiac transplantation from November 1985 through December 2005 at Loma Linda University Children's Hospital were retrospectively reviewed. The pre-transplantation diagnosis was used to divide patients into 3 groups: primary cardiomyopathy (CM), 103; hypoplastic left heart syndrome (HLHS), 154; and other complex congenital heart disease (CCHD), 160. These groups were compared and analyzed for differences in early and late morbidity and mortality.
RESULTS: Operative mortality was significantly lower in the CM group compared with the HLHS (p < 0.02;) and CCHD groups (p < 0.01). Long-term actuarial recipient survival, however, was similar for all groups. The 15-year actuarial survival was 59% for the CM Group, 57% for the HLHS Group, and 50% for the CCHD Group. Actuarial survival after retransplantation is not statistically different from that with primary cardiac transplantation.
CONCLUSION: Although peri-operative survival was lower in infants and children with HLHS and CCHD compared with those with CM, long-term survival has been the same for all groups. Late survival after retransplantation was not statistically different than among those with primary cardiac transplantation.

Entities:  

Mesh:

Year:  2008        PMID: 18926399     DOI: 10.1016/j.healun.2008.07.003

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  7 in total

1.  Outcomes in children after intestinal transplant.

Authors:  Oliver B Lao; Patrick J Healey; James D Perkins; Simon Horslen; Jorge D Reyes; Adam B Goldin
Journal:  Pediatrics       Date:  2010-02-08       Impact factor: 7.124

2.  Steroid avoidance in pediatric heart transplantation results in excellent graft survival.

Authors:  Scott R Auerbach; Jane Gralla; David N Campbell; Shelley D Miyamoto; Biagio A Pietra
Journal:  Transplantation       Date:  2014-02-27       Impact factor: 4.939

3.  Graft survival is better without prior surgery in cardiac transplantation for functionally univentricular hearts.

Authors:  Scott R Auerbach; Jilayne K Smith; Jane Gralla; Max B Mitchell; David N Campbell; Jim Jaggers; Biagio A Pietra; Shelley D Miyamoto
Journal:  J Heart Lung Transplant       Date:  2012-07-11       Impact factor: 10.247

4.  Absence of donor-specific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age?

Authors:  S Urschel; P M Campbell; S R Meyer; I M Larsen; J Nuebel; J Birnbaum; H Netz; K Tinckam; T Kauke; K Derkatz; J Y Coe; J L Platt; L J West
Journal:  Am J Transplant       Date:  2009-11-24       Impact factor: 8.086

5.  Outcome of pediatric patients with dilated cardiomyopathy listed for transplant: a multi-institutional study.

Authors:  Richard Kirk; David Naftel; Timothy M Hoffman; Christopher Almond; Gerard Boyle; Randall L Caldwell; James K Kirklin; Kirstie White; Anne I Dipchand
Journal:  J Heart Lung Transplant       Date:  2009-09-26       Impact factor: 10.247

6.  Late outcome after paediatric heart transplantation in Finland.

Authors:  Alireza Raissadati; Jaana Pihkala; Timo Jahnukainen; Eero Jokinen; Hannu Jalanko; Heikki Sairanen
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-03-30

Review 7.  Heart transplantation in biventricular congenital heart disease: indications, techniques, and outcomes.

Authors:  Bassem N Mora; Charles B Huddleston
Journal:  Curr Cardiol Rev       Date:  2011-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.